Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.
Journal of affective disorders February 15, 2023 Priel Meir, Leslie Taylor, Jair C Soares et al. 25 citations
Most psychologists are willing to inform eligible patients about psilocybin-assisted therapy if it becomes FDA-approved, but over 90% would still recommend non-psilocybin psychotherapies first. Among 119 surveyed psychologists, 77.4% agreed they would inform patients about PAT, yet 91.6% would prioritize other therapies. Three-quarters endorsed that more knowledge about psilocybin would increase their likelihood of informing patients. Greater openness to engaging patients with PAT was associated with more positive attitudes and beliefs about psilocybin, greater self-reported knowledge, personal psychedelic use, and positive attitudes toward medical cannabis. Attitudes toward medical cannabis and beliefs about psilocybin were the only significant predictors of openness in regression analysis.